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Background:  Ongoing clinical trials using the Impella device in high-risk percutaneous coronary intervention (PCI) exclude patients with aortic 
stenosis (AS). We present a single center experience with the use of Impella to support cardiac interventions in high-risk patients with AS.
Methods:  A total of 11 patients with AS who were high-risk for surgery underwent percutaneous procedures with concomitant Impella 2.5 support. 
There were 2 cases of balloon aortic valvuloplasty (BAV), 4 cases of high-risk PCI, and 4 cases of BAV followed by PCI. In one case, Impella was used 
to manage acute aortic regurgitation post BAV. Hemodynamics were assessed at baseline and during Impella support.
Results:  AS was severe in 8 patients and moderate in 3 patients. Patients had a mean age of 82 years old, STS score of 13.2%, and ejection 
fraction of 19%. In all cases the Impella catheter was advanced into the left ventricle without complications. Hemodynamic measurements were 
compared at baseline and during support with Impella as depicted in the table below.
Baseline Impella % Change p value
Mean PAP 39.8 ± 16.9 35.8 ± 11.3 -8.7% 0.36
Mean PCWP 23.9 ± 14.2 24.1 ± 10.5 -4% 0.93
LVEDP 27 ± 9.3 18.8 ± 8.3 -32% 0.02
CI 1.5 ± 0.6 2.5 ± 0.8 46% 0.01
Systolic BP 114.9 ± 25.1 136.7 ± 18.1 19% <0.01
MAP 83.6 ± 15.4 99.9 ± 10.2 20% <0.01
PAP: pulmonary artery pressure, PCWP: pulmonary capillary wedge pressure;LVEDP: left ventricular end-diastolic pressure, CI: cardiac Index, BP: blood 
pressure; MAP: mean arterial pressure
Conclusions:  In this pilot experience, all procedures were successfully completed using Impella 2.5 for hemodynamic support in a cohort of high-
risk AS patients. Further studies are needed to better define the role of Impella 2.5 in AS patients undergoing BAV with or without PCI.
